Related references
Note: Only part of the references are listed.Nicotinamide N-methyltransferase protein expression in renal cell cancer
Jun Zhang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2010)
MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
Sai-Wen Tang et al.
CANCER LETTERS (2009)
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer
Mikio Tomida et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
Jongmin Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration
Y. Wu et al.
ONCOGENE (2008)
Current insights in renal cell cancer pathology
Vito Mancini et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor
Myung-Jin Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TGF-β-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells
Eun-Sook Kim et al.
CANCER LETTERS (2007)
Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma
Davide Sartini et al.
MOLECULAR MEDICINE (2007)
Targeted molecular therapy for renal cell carcinoma
Brian R. Lane et al.
UROLOGY (2007)
Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-jun NH2-terminal kinase -: Mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9
Lydia W. T. Cheung et al.
CANCER RESEARCH (2006)
Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells
Hyun Song et al.
CANCER RESEARCH (2006)
Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma
Davide Sartini et al.
JOURNAL OF UROLOGY (2006)
Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification
Bo-Hyun Lim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Differentiating pancreatic lesions by Microarray and QPCR analysis of pancreatic juice RNAs
Carmelle D. Rogers et al.
CANCER BIOLOGY & THERAPY (2006)
Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1
In Hwa Bae et al.
CANCER RESEARCH (2006)
Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library
SW Tang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the αvβ1 integrin and focal adhesion kinase signaling pathway
B Hu et al.
CANCER RESEARCH (2006)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sp transcription factor family and its role in cancer
S Safe et al.
EUROPEAN JOURNAL OF CANCER (2005)
Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer
M Roessler et al.
CLINICAL CANCER RESEARCH (2005)
Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma
M Yao et al.
JOURNAL OF PATHOLOGY (2005)
Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery
T Ishimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2004)
Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism
N Pore et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2
H Ito et al.
CANCER RESEARCH (2004)
Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells
JM Xu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Molecular mechanisms of glioma invasiveness: The role of proteases
JS Rao
NATURE REVIEWS CANCER (2003)
Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer
K Vasala et al.
UROLOGY (2003)
Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma
M Takahashi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2002)
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM
DK Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas
H Maeta et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Share Paper
